Home Tags Rebates
Dispensed: Layoffs at uBiome, why mental health funding is booming, and Microsoft’s bet on partnerships with Walgreens and Providence
Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.
Everybody is talking about the high cost of prescription drugs. Here’s who’s actually responsible for the prices you pay.
Here's a look at all the companies involved in paying for a medication and why that can lead to higher prices.
Congress will grill 7 top pharma executives over the high cost of drugs today. Here’s how they’re set to shift the blame.
Pharma CEOs are likely to blame drug rebates for the high cost of their treatments, echoing an argument the industry has been using frequently.
The Trump administration just took its biggest step yet to bring down the cost of prescription drugs — and it’s dividing the healthcare in...
The aim is for patients to pay less for their drugs at the pharmacy counter, a major goal of the Trump administration.
In a move to hold drugmakers responsible for their products, Oklahoma's Medicaid program becomes the first-in-the-nation to implement a rebate program where it will only pay companies full price for the drug if it works as advertised.
‘IEX has sunk to a new low’: NYSE blasts upstart rival’s claims that it’s misleading its listed companies in brutal letter
NYSE claps back at IEX's accusations that it is misleading listed companies.
Ad agencies are paying out secret settlements so they don’t have to show clients all their contracts
The Association of National Advertisers report into media-transparency appears to have sparked a new type of settlement payout.
The Times also disclosed for the first time that it pays rebates to advertising and media-buying agencies.
The Guardian says it pays rebates in the form of "free advertising space, cash payments, or both."
Here’s what marketers are being advised to do 1 month on from the divisive ANA report into ad agency rebates
The ANA-commissioned Ebiquity Firm Decisions report is finally out.